Henry Ford Cancer Detroit (Brigitte Harris Cancer Pavilion) — Detroit, Michigan

Henry Ford Cancer Detroit (Brigitte Harris Cancer Pavilion) is a clinical research site located in Detroit, Michigan, United States 48202.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Henry Ford Cancer Detroit (Brigitte Harris Cancer Pavilion) has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Advanced MTAP-null Solid Tumors, Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation.

Sponsors: Amgen.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Henry Ford Cancer Detroit (Brigitte Harris Cancer Pavilion)?

Henry Ford Cancer Detroit (Brigitte Harris Cancer Pavilion) has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Henry Ford Cancer Detroit (Brigitte Harris Cancer Pavilion) conducted?

Henry Ford Cancer Detroit (Brigitte Harris Cancer Pavilion) has 2 clinical trials on record, with 2 currently active. Their work covers Advanced MTAP-null Solid Tumors, Advanced Solid Tumors, Kirsten Rat Sarcoma (KRAS) pG12C Mutation.

Is Henry Ford Cancer Detroit (Brigitte Harris Cancer Pavilion) accredited by Crixeo Health?

Henry Ford Cancer Detroit (Brigitte Harris Cancer Pavilion) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Henry Ford Cancer Detroit (Brigitte Harris Cancer Pavilion)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.